Skip to main content
. 2017 Sep 18;32(3):389–395. doi: 10.3803/EnM.2017.32.3.389

Fig. 4. Bone mineral density (BMD) changes after 12-week administration of each drug. Values represent percentage of change in BMD from the baseline value determined at the beginning of the experiment. Pio, pioglitazone; Rosi, rosiglitazone; Lobe, lobeglitazone. aP<0.05 vs. control group.

Fig. 4